Chapter 25 Pharmacogenomics and outcomes for hepatocellular cancer treatment
Ghanta M, Hussain M, Karnalkar A, Nagabhishek S, Nuthalapati P, Bhaskar L. Chapter 25 Pharmacogenomics and outcomes for hepatocellular cancer treatment. 2022, 401-414. DOI: 10.1016/b978-0-323-99283-1.00003-3.Peer-Reviewed Original ResearchHepatocellular carcinomaEffects of systemic treatmentRisk factorsPrevalence of genetic variantsSystemic therapy efficacyHepatocellular carcinoma recurrenceHuman genomeMultiple genesSingle-geneGenetic variantsSystemic treatmentPharmacogenomicsGenetic abnormalitiesTherapy efficacyViral infectionGenetic mutationsEconomic burdenPotential targetGeographic prevalenceEfficacyGenomeFood habitsRiskGenesCarcinoma